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ScienceDirectSystems genetics is defined as the simultaneous assessment
and analysis of multi-omics datasets. In the past few years,
metabolomics has been established as a robust tool describing
an important functional layer in this approach. The metabolome
of a biological system represents an integrated state of genetic
and environmental factors and has been referred to as a ‘link
between genotype and phenotype’. In this review, we
summarize recent progresses in statistical analysis methods for
metabolomics data in combination with other omics layers. We
put a special focus on complex, multivariate statistical
approaches as well as pathway-based and network-based
analysis methods. Moreover, we outline current challenges and
pitfalls of metabolomics-focused multi-omics analyses and
discuss future steps for the field.
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Introduction
In recent years, the biomedical research field has experi-
enced tremendous advancements in high-throughput
measurement technologies. Various layers of the central
molecular dogma are now well covered by so-called
‘omics’ data, including the assessment of DNA variation,
DNA modifications, transcript expression, protein abun-
dances and modifications, as well as metabolite profiles.
In human population studies, nowadays millions of mo-
lecular markers are screened across many omics levels in
thousands of samples. The promise of such multi-omics
datasets is to provide a holistic picture of the biological
system in health and disease, giving rise to an exciting
new branch of systems biology called ‘systems genetics’
[1]. The central idea is that only by simultaneously
assessing as many layers of the biological system asCurrent Opinion in Biotechnology 2016, 39:198–206 possible and, importantly, the complex interactions be-
tween them, we can develop a fundamental understand-
ing of the underlying mechanisms between genotype and
(patho)phenotype. The computational challenge is to
develop statistical approaches that identify the additional
knowledge expected to be buried in multi-omics datasets
[2].
Among the omics technologies, metabolomics plays a
special role. The metabolome is the set of all small
molecules, such as amino acids, sugars and lipids, in a
biological system. It is considered to be an endpoint of
biological processes and carries an imprint of all genetic,
epigenetic and environmental factors [3]. It has therefore
also been referred to as the ‘link between genotype and
phenotype’ [4] (Figure 1a). As a consequence, the major-
ity of biological and medical perturbations can be
expected to be visible in the metabolome, making me-
tabolites ideal biomarkers. Metabolomics has been par-
ticularly successful in the field of human epidemiology,
with studies ranging from neurological disorders over type
2 diabetes to cardiovascular disease [5].
In this review, we summarize recent papers and devel-
opments in the analysis of metabolomics data with other
molecular omics layers, with a special focus on studies in
the human system. We particularly discuss statistical and
computational methods, including pathway analysis, net-
works and multivariate integration methods. We deliber-
ately omit the discussion of public resources, such as
metabolic pathway and protein–protein interaction data-
bases, since this would be beyond the scope of this
review. For this topic, we refer the interested reader to
Ng et al. [6].
Metabolomics and DNA variation
High-throughput genotyping methods gave rise to large-
scale genome-wide association studies (GWAS) over a
decade ago [7], with the promise to elucidate the genetic
basis of complex diseases. Many traits have since been
correlated with single nucleotide polymorphisms (SNPs),
including metabolomics measurements from human
cohorts. Compared to other traits, a substantial amount
of metabolites in human blood have been reported with
remarkable heritability, showing exceptionally high frac-
tions of variance explained by common genetic variants
[8].
The first association study between genetic variation in
the general population and metabolic traits in blood
measured by mass-spectroscopy was performed by Gieger
et al. [9], based on 363 metabolites measured in 284 malewww.sciencedirect.com
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Systems metabolomics. (a) Complex interplay between molecular omics, environment and the phenotype. The different layers of the biological
system are nowadays well covered by various omics technologies. The metabolome is of special interest, since it integrates all molecular and
environmental effects. It is to be noted that this chart represents a simplified view of information flow which is still subject of active debate. (b)
Univariate associations between single metabolites and other omics markers are usually computed as a first line of analysis. These associations
can then either be visualized and further analyzed as multi-omics networks, or grouped into overrepresented pathways using pathway
enrichment analysis. (c) Multivariate methods exploit the usually high covariation of measurements within and between omics layers. Canonical
correlation analysis is shown as an example. It seeks to find canonical weight vectors, such that the resulting canonical variables b1X and b2Y
(X and Y representing the two data matrices), are maximally correlated. It then searches for the next pair of variables orthogonal to the first
ones, and so on.
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200 Systems biologyindividuals of the German KORA cohort. The authors
discovered that by using ratios of metabolites as meta-
bolic traits, the associations with SNPs increase dramati-
cally. Later studies steadily extended the number of
associating loci by increasing statistical power with thou-
sands of samples [10], larger panels of measured metab-
olites [8,11], urine as an alternative biomarker fluid
[12,13], NMR-based metabolite measurements  [14] and
non-Caucasian cohorts [15]. Metabolomics GWAS stud-
ies have identified hundreds of mQTLs, metabolomics
quantitative trait loci, involving a variety of metabolic
pathways. Notably, many genes occurring as top hits in
these studies have previously been described as disease-
related genes and drug targets [11]. A recent, compre-
hensive review of the metabolomics GWAS field can be
found in Kastenmu¨ller et al. [16].
Extending the common one SNP/one metabolite anal-
yses, several authors suggested to associate correlated
modules of metabolites with genetic variation. Such an
approach increases statistical power (due to a reduced
number of tests) while simultaneously removing un-
wanted variation in the data. For example, Inouye et al.
[17] used canonical correlation analysis (Figure 1c), a
multivariate extension of regular pairwise correlation, to
associate correlated metabolite modules with SNPs in a
GWAS. They identified several novel genetic loci that
had not been linked with metabolic traits before. In a
similar fashion, Ried et al. [18] defined metabolite
modules from partial correlation networks and associat-
ed them with genetic variation using a permutation-
based approach called ‘phenotype set enrichment
analysis’.
Several studies incorporated prior knowledge into the
analysis to functionally characterize the substantial
number of hits found in a metabolomics GWAS. The
straight-forward and commonly used approach for this
is gene set enrichment analysis (see e.g. Subramanian
et al. [19], Figure 2a). It assesses whether SNPs identi-
fied in metabolomics GWAS tend to statistically accu-
mulate in genes of predefined pathways. Two recent
studies followed this approach, identifying systematic
associations of lipid metabolites with the glycerolipid
pathway [20] and the acetyl-CoA dehydrogenase
pathway [21].
Finally, extending the concept of set-based analysis to a
more fine-grained level, our group used correlation anal-
ysis and Gaussian graphical models to establish a large-
scale map (an ‘atlas’) of statistical associations between
SNPs and metabolic pathways. This provided a detailed
in vivo picture of the influence of genetic variation on
metabolism in humans [11,22] (Figure 2b). Future
studies could query this atlas, for example, to identify
candidate genes for metabolites that have been associated
with a disease phenotype.Current Opinion in Biotechnology 2016, 39:198–206 Metabolomics and transcriptomics
Another molecular layer frequently correlated with meta-
bolomics data are gene expression profiles. Transcrip-
tomics is a well-established measurement technology
enabling the genome-wide assessment of gene expres-
sion. Coding transcripts are frequently used as proxies for
protein levels, the direct physical interaction partners of
metabolites. Moreover, in contrast to genetic data, tran-
script profiles also reflect environmental and lifestyle
influences. Pioneering efforts for integrated metabolo-
mics/transcriptomics analyses have been made in plant
research, with papers that are now highly acknowledged
in the field [23,24]. A recent review summarizes different
strategies and methods for the integration of metabolo-
mics and transcriptomics data [25], including challenges
with respect to experimental design and general multi-
omics analysis strategies.
Multivariate statistical methods, which model the shared
covariance between datasets, have become particularly
important to associate high-dimensional, quantitative
omics measurements. Simple univariate analyses, that
is, comparing one metabolite and one transcript at a time,
do not account for correlation structures within each
omics level and are thus not able to capture the complex
interplay between them. The general concept of multi-
variate methods is to find highly correlating directions
(components, clusters) of markers within each dataset,
which can then be associated between datasets (cf.
Figure 1c). These methods include partial least squares
(PLS) regression [26], O2-PLS [27] and canonical corre-
lation analysis [28]. Griffin et al. used PLS regression to
analyze time-resolved metabolomics and transcriptomics
data of rat liver tissue to study fatty liver disease [26]. The
authors identified systematic changes in lipid metabolism
affected at both the transcriptional and metabolic level.
Jozefczuk et al. used canonical correlation analysis to
analyze the time-dependent metabolic and transcrip-
tomic stress response of E. coli [28]. They were able to
monitor metabolic adaptations to environmental condi-
tions over time, identifying numerous condition-depen-
dent associations between metabolites and transcripts. In
a related approach, Wahl et al. used ‘weighted correlation
network analysis’ (WGCNA) to separately define clusters
of metabolites and transcripts, which were then correlated
and later associated with weight gain in humans [29].
Extending the above-mentioned, purely statistical
approaches, several authors suggested the use of prior
knowledge in pathway-based methods for the joint anal-
ysis of metabolomics and transcriptomics. Su et al.
mapped correlations computed in the NCI60 cancer cell
line dataset onto a metabolic network model to identify
correlating metabolite/transcript pairs involved in the
same metabolic reactions or the same metabolic pathways
[30]. Similarly, C¸ akir et al. mapped metabolites and
transcripts to a genome-scale metabolic model in yeastwww.sciencedirect.com
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Integration of metabolomics data and SNPs. GWAS with metabolic traits generate significantly correlating SNP-metabolite pairs. (a) To determine
which pathways accumulate a significant amount of metabolite-associating SNPs, gene set enrichment analysis can be performed (example in
[21]). (b) Integrating metabolite and SNP associations into a network view provides a detailed picture of in vivo pathway associations (panel B
adapted from [22]).in order to identify different modes of metabolic regula-
tion [31]. The need for pathway-based analysis methods
also gave rise to publically available toolboxes. One of the
first projects was the ‘Integrated Molecular Pathway-
Level Analysis’ (IMPaLA) web tool, which provides
pathway enrichment tools for joint metabolomics/tran-
scriptomics datasets [32].
Only rather recently, several groups started to integra-
tively analyze metabolomics and transcriptomics datawww.sciencedirect.com from well-powered, large-scale human population
cohorts. For instance, Inouye et al. were the first to build
a large-scale correlation network from whole blood gene
expression data of more than 500 individuals [33]. The
authors investigated the association between a leukocyte-
specific gene expression module and circulating metab-
olites, mostly lipid parameters, in blood.
In a similar study, our group systematically analyzed the
interplay between serum metabolites and whole bloodCurrent Opinion in Biotechnology 2016, 39:198–206
202 Systems biologytranscriptomics data from more than 700 individuals on a
substantially wider metabolomics panel [34]. We con-
structed a correlation network, the human ‘Blood Metabo-
lome-Transcriptome Interface’, containing 114 metabolites
and 522 transcripts. This network was then subjected to a
series of bioinformatics analyses for further characteriza-
tion. In brief, we showed that blood correlations between
metabolites and transcripts represent parts of true meta-
bolic pathways, especially lipid transport and immune
system processes. We then identified signatures of cor-
egulation by performing transcription-factor binding site
enrichment analysis on all transcripts associated with a
given metabolite or metabolic pathway. Finally, mapping
statistical associations with HDL-C, LDL-C and TG,
known risk factors for common diseases, revealed various
pathways affected pathways in the network.
Metabolomics and proteomics
In contrast to the combination with transcriptomics data,
integrative analysis studies of metabolomics and proteo-
mics are still rare. While microarray-based and modern
sequencing-based methods assess the transcriptome pu-
tatively in a genome-wide fashion, the coverage of mass-
spectrometry-based peptide profiling is still limited [35].
Nevertheless, even at this early stage, integrating meta-
bolomics and proteomics data provides valuable insights
by investigating physically interacting molecules (metab-
olites and proteins) which are tightly connected to the
phenotype. Importantly, merely investigating transcripts
as proxies for proteins is not always sufficient due to the
well-described discrepancy between protein concentra-
tions and their respective coding mRNAs levels [36].
First studies on joint metabolomics/proteomics measure-
ments also originated in the field of plant biology, for
example to assign new enzymatic functions to proteins
[37] and to gain mechanistic insights into plant-specific
biochemical processes [38]. Wienkoop et al. used inde-
pendent component analysis (ICA) combined with corre-
lation networks to study the stress-induced associations
between metabolites and proteins in Arabidopsis thaliana
[39]. In the human system, Oberbach et al. used ICA to
analyze time-resolved serum metabolomics and proteo-
mics data from lean and obese healthy participants of a
challenging study, revealing molecules and pathways
associated with obesity [40] (Figure 3a).
Similar to other omics combinations, specific methods
have been developed to incorporate prior knowledge into
the analysis process. For instance, integrative omics-met-
abolic analysis (IOMA) quantitatively integrates metabo-
lomics and proteomics data into genome-wide metabolic
models to predict kinetic rates under given experimental
conditions [41]. To this end, it formulates a quadratic
programming optimization problem to compute a set of
metabolic fluxes which are compatible with rates inferred
from the metabolomics and proteomics measurements. AsCurrent Opinion in Biotechnology 2016, 39:198–206 another example, our group developed a method to
identify regulated regions in metabolic pathways which
show differential concentrations of both metabolites
and proteins under different experimental conditions
[42]. The method is based on a random walk algorithm
and attempts to combine ‘seed’ nodes with strong dif-
ferential changes in the network into modules
(Figure 3b). We applied the method to identify regu-
lated pathways in Jurkat T cells stimulated with an
environmental pollutant.
Future perspectives and challenges
The field of metabolomics is now firmly established in
systems genetics, and substantial improvements in multi-
omics analysis methods have already been achieved in the
past years. In the following, we will outline future direc-
tions and current challenges.
Commonly in biomedical research, major advances in the
field can be expected from more efficient and precise
measurement technology. For example, there are major
efforts to further develop mass-spectrometry-based tech-
niques [43], in order to provide true ‘metabolomes’
covering the entirety of molecules in the biological sys-
tem. In addition, more fine-grained omics technologies
are currently being established, for instance covering
post-translational modifications, such as glycoproteomics
[44] and quantitative phosphoproteomics [45]. Integrat-
ing these novel technologies with metabolomics data will
create interesting new computational challenges.
A crucial prerequisite to further advance the multi-omics
research field will be the establishment of data processing
standards and data depositing infrastructure. For exam-
ple, in contrast to microarray-based and sequencing-based
transcriptomics, there are no standardized pipelines for
the normalization and quality control of mass-spectrome-
try-based metabolomics data. Different groups follow
different approaches, and standardization efforts would
facilitate reproducibility of results and increase overall
research quality. On a related note, for gene expression
data there are central data repositories, such as the Gene
Expression Omnibus, GEO [46], which gives scientists
open access to the raw data of published studies. For
metabolomics, valuable first steps in this direction have
been made with the MetaboLights project [47], but
more comprehensive efforts are required to achieve a
higher coverage of publically available data.
On the analysis side, the metabolomics field should further
adopt and extend methods from other ‘omics disciplines.
For example, substantial efforts have been made to anno-
tate and prioritize GWAS hits using functional annotations
from ENCODE and related projects [48]. Similar
approaches could be used to gain further insights into
the nature and functional relevance of mQTLs. Moreover,
extended GWAS methods are currently being developed,www.sciencedirect.com
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Integration of metabolomics and proteomics data. (a) Independent component analysis on proteomics data, metabolomics data, and the
combined data set. While there is no clear separation of experimental groups with any of the two omics alone, the combination of both provides a
substantially stronger signal. Inspired by results from Oberbach et al. [40]. (b) Module identification by a random walk algorithm. The algorithm
identifies pathway modules with a high abundance of significantly changed proteins and metabolites, here called ‘seed’ nodes. Algorithm was
used in Baumann et al. [42].such as prior knowledge-based ranking methods to identify
pathways shared across different diseases [49]. Another
branch of methods that should be further extended for
multi-omics studies are machine-learning approaches,
such as support vector machines, Bayesian networks and
neural networks. For instance, Zhu et al. integrated meta-
bolomics and transcriptomics data using Bayesian net-
works to construct causal regulatory networks in yeast [50].
One layer of molecular biology that we have not sys-
tematically addressed in this review are epigeneticwww.sciencedirect.com modifications. Systematic high-throughput assessment
of DNA methylation is possible today by microarray-based
and sequencing technologies [51]. To the best of our
knowledge, only a single epigenome-wide association study
(EWAS) with systematic metabolomics measurements has
been published to date [52]. The authors reported 15 hits
between metabolome and epigenome in humans and,
importantly, point out various challenges in the assessment
and interpretation of such associations. For example, cor-
relations between CpG sites and metabolites are particu-
larly confounded by underlying genetic variation andCurrent Opinion in Biotechnology 2016, 39:198–206
204 Systems biologyenvironmental factors, thereby complicating direct func-
tional interpretations. Since the metabolomics/epigenetics
field is still young, pathway-based and network-based
methods will have to be developed and applied after solving
the fundamental issue of result interpretation.
Another upcoming omics layer not addressed here is the
gut microbiome. Results from recent studies integrating
metabolomics with metagenomics data from the human
intestinal surface [53] or fecal samples [54] already
revealed strong interactions between metabolism and
gut microbiota. However, the field of metagenomics is
still in its infancy, and further experimental and statistical
methods need to be developed to infer true microbial
compositions from DNA sequencing data.
Following up on result interpretation, associations be-
tween omics layers often raise the question of effect
direction and causality. For genetic data, effect direction
is a trivial issue due to the obvious immutability of the
germline DNA. For any other omics level, assessment of
causality poses a highly complex problem. If the effect
directionality is not given by the study design, for exam-
ple, in longitudinal studies, the possibilities to assess
directionality become quite limited. Previous studies
have attempted to model causality between two omics
layers using SNPs as instrumental variables in structural
equation modeling (SEM) [55,56] or Mendelian random-
ization [34,57]. These approaches exploit the natural
randomization of genotypes in an attempt to mimic ran-
domized controlled trials, the gold standard to assess
causality. However, most studies still lack statistical power
and make strong, possibly false assumptions on the absence
of confounding factors. Thus, substantial developments
are still necessary to truly infer causal links from data.
Leaving the field of purely observational analyses, mech-
anistic models that define precise kinetic relationships of
enzymatic reactions and transport processes will be a
major next step in the metabolomics/multi-omics inte-
gration field. For unicellular model organisms, such as
E. coli and yeast, detailed insights into the regulation of
cellular metabolism have been established in the past
years. For example, Fendt et al. [58] provide a detailed
analysis of the relationship between enzyme capacity and
metabolic concentrations in S. cerevisiae. In the human
system, first steps have been taken towards the develop-
ment of systematic mechanistic models, such as a whole-
cell kinetic model of the human erythrocyte [59]. Future
studies will have to face the challenge of a complex,
multi-compartmental system in higher organisms, espe-
cially in the light of multi-omics datasets.
The ultimate application of system genetics will be large-
scale, possibly longitudinal studies of pathophenotypes
with simultaneous measurements for all omics layers,
including phenotypic information (the phenome) [60].Current Opinion in Biotechnology 2016, 39:198–206 This represents the transition from ‘systems genetics’ to
‘systems medicine’, that is, the patient-centric view on
multi-omics data [61]. A recent, famous study in this
direction was the ‘integrative personal omics profile,
iPOP’ study [62], where a single individual was monitored
over a 14-month period with time-resolved measure-
ments of genomics, transcriptomics, proteomics, metabo-
lomics and clinical data. As outlined in this review,
integrating and analyzing two omics layers at a time
has already proved complicated, and the actual benefit
and novel insights of true multi-omics datasets still
remains to be demonstrated. Novel computational meth-
ods must be developed to process and analyze the massive
data sets that will be produced.
We believe that metabolomics, as an established, strong
link between genotype and phenotype, will continue to
play a major role in the systems genetics field. Advance-
ments both on the measurement and especially on the
analysis side will produce exciting novel insights in the
years to come.
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